No Image Available
No Purchase Links Available
The AstraZeneca COVID-19 vaccine, developed by AstraZeneca and the University of Oxford, is a viral vector vaccine designed to protect against the SARS-CoV-2 virus. It was widely used globally during the pandemic. The speaker mentions someone who was injured during its trials.
Brienne Dresen who was injured during the Astroenica CO 19 trials.
""The speaker discusses a specific person who was injured during the trials of the AstraZeneca COVID-19 vaccine, highlighting its role in the broader conversation about vaccine safety and experimental treatments."